HOCl is naturally produced by white blood cells in the human body.

HOCl was first synthesized by French scientist Antoine Jérôme Balard.

The first known clinical use of HOCl was during WWI to irrigate and disinfect wounds.

Since 1945, over 1200 articles have been written about the clinical use of HOCl.

FDA cleared 510(k) and NeutroPhase is released.

Dr. Jack Fisher started using HOCl clinically in surgery after using it for several years for chronic wound management.

NeutroPhase and PhaseOne consolidate to bring new innovations to the HOCl market.